Page last updated: 2024-10-23

azathioprine and Anemia, Leukoerythroblastic

azathioprine has been researched along with Anemia, Leukoerythroblastic in 2 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mey, U1
Heimpel, H1
Dietrich, M1
Erdmann, H1

Other Studies

2 other studies available for azathioprine and Anemia, Leukoerythroblastic

ArticleYear
[Immunosuppressive agents or splenectomy in hematologic autoaggressive diseases? Clinical experiment report].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1972, Mar-15, Volume: 27, Issue:6

    Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Anemia, Myelophthisic; Autoimmune Diseases;

1972
[Azathioprine treatment of panmyelopathy with severe amegakaryocytic thrombocytopenia in children].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1968, Volume: 74

    Topics: Anemia, Myelophthisic; Azathioprine; Child, Preschool; Female; Humans; Thrombocytopenia

1968